Last reviewed · How we verify
NCT04603053
Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT
NA trial testing mHealth app in Adolescent Depression in 18 participants. Completed in 20 August 2021.
20 August 2021
Quick facts
| Lead sponsor | Washington University School of Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 9 November 2020 |
| Primary completion | 20 August 2021 |
| Estimated completion | 20 August 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- mHealth app
Conditions studied
- Adolescent Depression — all drugs for Adolescent Depression →
- Anxiety Disorders — all drugs for Anxiety Disorders →
Sponsor
Washington University School of Medicine
Who can join
Adults 12 to 17, any sex, with Adolescent Depression or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Washington University will evaluate the acceptability and effectiveness of a mobile health (mHealth) intervention to provide cognitive behavioral therapy for adolescents with depression.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study.
Nicol G, Wang R, Graham S, Dodd S, et al · · 2022 · cited 58× · PMID 36413390 · DOI 10.2196/40242
Verify or expand the search:
- PubMed search for NCT04603053
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of mHealth app
Trials testing the same drug.
- NCT06292260 — Digital Toolkit for Skin Diseases in LMICs: Part 2 · NA · recruiting
- NCT04239911 — Leveraging Home Health Aides to Improve Outcomes in Heart Failure · NA · completed
- NCT06361056 — Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials · NA · completed
- NCT05300399 — Digital Toolkit for Skin Diseases in LMICs · NA · unknown
- NCT04858295 — Supporting Self-Management of Healthy Behaviors in Chronic Kidney Disease · NA · completed
Other Washington University School of Medicine trials
Trials by the same sponsor.
- NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
- NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
- NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
- NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
- NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04603053 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
- Last refreshed: 19 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04603053.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing